09:14 AM EDT, 03/16/2026 (MT Newswires) -- Health care stocks were flat to higher premarket Monday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF ( XLV ) up 0.5%.

CytomX Therapeutics ( CTMX ) shares were up more than 48% after the company said a phase 1 clinical trial evaluating varsetatug masetecan in patients with advanced colorectal cancer yielded confirmed response rates of up to 32%.

Olema Pharmaceuticals ( OLMA ) stock was up more than 5% after the company reported a narrower Q4 net loss.

Esperion Therapeutics ( ESPR ) shares were up more than 3% after the company said its cholesterol lowering therapy bempedoic acid received multiple Class 1 recommendations in the 2026 American College of Cardiology/American Heart Association multisociety guideline for the management of dyslipidemia.